| Title |
Edaravone for acute ischaemic stroke
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2011
|
| DOI | 10.1002/14651858.cd007230.pub2 |
| Pubmed ID | |
| Authors |
Shejun Feng, Qingwei Yang, Ming Liu, Weizheng Li, Wenming Yuan, Shihong Zhang, Bo Wu, Juntao Li |
| Abstract |
Neuroprotection is a promising therapeutic strategy for the treatment of acute ischaemic stroke. Edaravone is a neuroprotective agent that has been widely used in China, and several studies have suggested that it may be beneficial in acute ischaemic stroke. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 4 | 50% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Unknown | 103 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 13% |
| Researcher | 12 | 12% |
| Student > Ph. D. Student | 11 | 11% |
| Professor > Associate Professor | 6 | 6% |
| Student > Bachelor | 6 | 6% |
| Other | 23 | 22% |
| Unknown | 32 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 34% |
| Nursing and Health Professions | 7 | 7% |
| Neuroscience | 6 | 6% |
| Agricultural and Biological Sciences | 4 | 4% |
| Computer Science | 3 | 3% |
| Other | 13 | 13% |
| Unknown | 36 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2016.
All research outputs
#7,024,985
of 25,805,386 outputs
Outputs from Cochrane database of systematic reviews
#8,523
of 13,140 outputs
Outputs of similar age
#56,795
of 249,159 outputs
Outputs of similar age from Cochrane database of systematic reviews
#108
of 213 outputs
Altmetric has tracked 25,805,386 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,159 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 213 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.